tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

TOVX Stock Latest News

Theriva Biologics Presents Promising VCN-01 Study Results
Company AnnouncementsTheriva Biologics Presents Promising VCN-01 Study Results
9d ago
8K
TOVX
Theriva Biologics announces presentation of data from VCN-01 Phase 1 trial
PremiumThe Fly
Theriva Biologics announces presentation of data from VCN-01 Phase 1 trial
15d ago
TOVX
Theriva Biologics reports Q1 EPS ($1.55) vs ($7.53) last year
PremiumThe Fly
Theriva Biologics reports Q1 EPS ($1.55) vs ($7.53) last year
27d ago
TOVX
Theriva Biologics sees cash runway into 1Q26
PremiumThe Fly
Theriva Biologics sees cash runway into 1Q26
27d ago
TOVX
Theriva Biologics Completes $7.5 Million Public Offering
PremiumCompany Announcements
Theriva Biologics Completes $7.5 Million Public Offering
1M ago
8K
TOVX
Theriva Biologics downgraded to Hold from Buy at Maxim
PremiumThe FlyTheriva Biologics downgraded to Hold from Buy at Maxim
1M ago
TOVX
Theriva Biologics downgraded to Hold from Buy at Maxim
Premium
The Fly
Theriva Biologics downgraded to Hold from Buy at Maxim
1M ago
TOVX
Theriva Biologics prices 6.8M shares at $1.10 in public offering
Premium
The Fly
Theriva Biologics prices 6.8M shares at $1.10 in public offering
1M ago
TOVX
Theriva Biologics announces primary endpoints for efficacy met in VIRAGE study
PremiumThe Fly
Theriva Biologics announces primary endpoints for efficacy met in VIRAGE study
1M ago
TOVX
Theriva Biologics Announces Positive VIRAGE Phase 2b Results
PremiumCompany Announcements
Theriva Biologics Announces Positive VIRAGE Phase 2b Results
1M ago
8K
TOVX
Theriva Biologics Reports Positive VIRAGE Phase 2b Results
PremiumCompany Announcements
Theriva Biologics Reports Positive VIRAGE Phase 2b Results
2M ago
8K
TOVX
Theriva Biologics says IDMC considers VCN-01 to be well tolerated
PremiumThe Fly
Theriva Biologics says IDMC considers VCN-01 to be well tolerated
2M ago
TOVX
Theriva Biologics Reports 2024 Financial Results and Progress
PremiumCompany AnnouncementsTheriva Biologics Reports 2024 Financial Results and Progress
3M ago
TOVX
Theriva Biologics files to sell 7.69M shares of common stock, warrants
Premium
The Fly
Theriva Biologics files to sell 7.69M shares of common stock, warrants
6M ago
TOVX
Theriva Biologics Advances VCN-01 with FDA Guidance
Premium
Company Announcements
Theriva Biologics Advances VCN-01 with FDA Guidance
6M ago
8K
TOVX
Theriva Biologics announces U.S. FDA guidance of Phase 3 study design
PremiumThe Fly
Theriva Biologics announces U.S. FDA guidance of Phase 3 study design
6M ago
TOVX
Theriva Biologics Highlights Key Achievements in Q3 2024
PremiumCompany Announcements
Theriva Biologics Highlights Key Achievements in Q3 2024
7M ago
TOVX
Theriva Biologics price target lowered to $6 from $25 at Maxim
PremiumThe Fly
Theriva Biologics price target lowered to $6 from $25 at Maxim
7M ago
TOVX
Theriva Biologics reports Q3 EPS ($6.81) vs. ($4.85) last year
PremiumThe Fly
Theriva Biologics reports Q3 EPS ($6.81) vs. ($4.85) last year
7M ago
TOVX
3 Penny Stocks to Watch Now, 11/5/24
PremiumMarket News3 Penny Stocks to Watch Now, 11/5/24
7M ago
ATHA
TOVX
Theriva Biologics Expands Stock Plans and Share Authority
Premium
Company Announcements
Theriva Biologics Expands Stock Plans and Share Authority
7M ago
8K
TOVX
Theriva Biologics picked as finalist in competition for Merck KGaA’s EMEA grant
Premium
The Fly
Theriva Biologics picked as finalist in competition for Merck KGaA’s EMEA grant
7M ago
TOVX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >